Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10495-024-02022-8.

Title:
Emerging druggable targets for immune checkpoint modulation in cancer immunotherapy: the iceberg lies beneath the surface | Apoptosis
Description:
The immune system serves as a fundamental defender against the initiation and progression of cancer. Failure of the immune system augments immunosuppressive action that leading to cancer manifestation. This immunosuppressive effect causes from significant alterations in immune checkpoint expression associated with tumoral progression. The tumor microenvironment promotes immune escape mechanisms that further amplifying immunosuppressive actions. Notably, substantial targeting of immune checkpoints has been pragmatic in the advancement of cancer research. This study highlights a comprehensive review of emerging druggable targets aimed at modulating immune checkpoint co-inhibitory as well as co-stimulatory molecules in response to immune system activation. This modulation has prompted to the development of newer therapeutic insights, eventually inducing immunogenic cell death through immunomodulatory actions. The study emphasizes the role of immune checkpoints in immunogenic regulation of cancer pathogenesis and explores potential therapeutic avenues in cancer immunotherapy. Graphical Abstract Modulation of Immunosuppressive and Immunostimulatory pathways of immune checkpoints in cancer immunotherapy
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

pubmed, article, google, scholar, cas, central, cancer, immune, cell, immunotherapy, immunol, checkpoint, cells, zhang, httpsdoiorgs, wang, chen, front, oncol, targeting, res, tumor, patients, clin, httpsdoiorgfimmu, liu, therapy, med, mol, clinical, role, zhao, receptor, zhou, expression, tcell, lee, carcinoma, phase, httpsdoiorg, kim, rev, sci, immunity, vista, targets, antibodies, receptors, signaling, immunother,

Topics {✒️}

bifunctional anti-pd-l1/tgf-βrii agent bifunctional anti-pd-l1/tgfβrii agent tumour-induced t-cell desertification anti-pd-1/l1 treatment-naïve head protein-coupled receptor-mediated signaling anti-ox40-mediated tumor rejection tumor-expressed b7-h3 mediates month download article/chapter immune receptors b7-h3/cd276 pd-1/pd-l1 blockade monotherapy tumor-antigen-binding bispecific antibodies support cd8 + t-cell proliferation anti- pd-l1 antibody targeting tgf-β isoforms cd4+ t-cell differentiation b-cell-based immunotherapy pd-1/pd-l1 pathway enhanced anti-tumor activity immune-related adverse events regulating anti-tumor immunity pd-1/pd-l1 blockade membrane b7-h3 expression cd8 t-cell densities tim-3/gal-9/bat3 pathway immune checkpoints pd-l1 exert tumor-suppressive action article apoptosis aims antitumor t-cell functions human t-cell response multi-lineage immune checkpoint cd8 t-cell responses treg cell-based therapies pd-1/pd-l1 + tumors b7-h3/cd276 ifn-γ-dependent cytotoxicity pd/1-pd-ls checkpoint full article pdf exhausted tumor-infiltrating cd8+ anti- tim-3 antibody tumor-targeted 4-1bb agonists targeting b7-h3 dual anti-pd lag-3 + tumor infiltrating lymphocytes 1/tgf-β inhibitors phase ia/ib study related subjects immune checkpoint molecule emerging druggable targets soluble b7-h3 b7-h3 inhibits

Questions {❓}

  • Musielak B, Kocik J, Skalniak L, Magiera-Mularz K, Sala D, Czub M, Stec M, Siedlar M, Holak TA, Plewka J (2019) CA-170 - a potent small-molecule PD-L1 inhibitor or not?
  • Wikenheiser DJ, Stumhofer JS (2016) ICOS Co-stimulation: friend or foe?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Emerging druggable targets for immune checkpoint modulation in cancer immunotherapy: the iceberg lies beneath the surface
         description:The immune system serves as a fundamental defender against the initiation and progression of cancer. Failure of the immune system augments immunosuppressive action that leading to cancer manifestation. This immunosuppressive effect causes from significant alterations in immune checkpoint expression associated with tumoral progression. The tumor microenvironment promotes immune escape mechanisms that further amplifying immunosuppressive actions. Notably, substantial targeting of immune checkpoints has been pragmatic in the advancement of cancer research. This study highlights a comprehensive review of emerging druggable targets aimed at modulating immune checkpoint co-inhibitory as well as co-stimulatory molecules in response to immune system activation. This modulation has prompted to the development of newer therapeutic insights, eventually inducing immunogenic cell death through immunomodulatory actions. The study emphasizes the role of immune checkpoints in immunogenic regulation of cancer pathogenesis and explores potential therapeutic avenues in cancer immunotherapy. Modulation of Immunosuppressive and Immunostimulatory pathways of immune checkpoints in cancer immunotherapy
         datePublished:2024-10-01T00:00:00Z
         dateModified:2024-10-01T00:00:00Z
         pageStart:1879
         pageEnd:1913
         sameAs:https://doi.org/10.1007/s10495-024-02022-8
         keywords:
            Cancer immunotherapy
            Immune cells
            Co-inhibitory immune checkpoints
            Co-stimulatory immune checkpoints
            Immunomodulation
            Cancer Research
            Cell Biology
            Oncology
            Biochemistry
            general
            Virology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-024-02022-8/MediaObjects/10495_2024_2022_Figb_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-024-02022-8/MediaObjects/10495_2024_2022_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-024-02022-8/MediaObjects/10495_2024_2022_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-024-02022-8/MediaObjects/10495_2024_2022_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-024-02022-8/MediaObjects/10495_2024_2022_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-024-02022-8/MediaObjects/10495_2024_2022_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-024-02022-8/MediaObjects/10495_2024_2022_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-024-02022-8/MediaObjects/10495_2024_2022_Fig8_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-024-02022-8/MediaObjects/10495_2024_2022_Fig9_HTML.png
         isPartOf:
            name:Apoptosis
            issn:
               1573-675X
               1360-8185
            volumeNumber:29
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Sakuntala Gayen
               affiliation:
                     name:NSHM Knowledge Campus, Kolkata-Group of Institutions
                     address:
                        name:Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata-Group of Institutions, Kolkata, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Swarupananda Mukherjee
               affiliation:
                     name:NSHM Knowledge Campus, Kolkata-Group of Institutions
                     address:
                        name:Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata-Group of Institutions, Kolkata, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sandipan Dasgupta
               affiliation:
                     name:Maulana Abul Kalam Azad University of Technology
                     address:
                        name:Department of Pharmaceutical Technology, Maulana Abul Kalam Azad University of Technology, Kolkata, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Souvik Roy
               url:http://orcid.org/0000-0003-2980-0362
               affiliation:
                     name:NSHM Knowledge Campus, Kolkata-Group of Institutions
                     address:
                        name:Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata-Group of Institutions, Kolkata, India
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Emerging druggable targets for immune checkpoint modulation in cancer immunotherapy: the iceberg lies beneath the surface
      description:The immune system serves as a fundamental defender against the initiation and progression of cancer. Failure of the immune system augments immunosuppressive action that leading to cancer manifestation. This immunosuppressive effect causes from significant alterations in immune checkpoint expression associated with tumoral progression. The tumor microenvironment promotes immune escape mechanisms that further amplifying immunosuppressive actions. Notably, substantial targeting of immune checkpoints has been pragmatic in the advancement of cancer research. This study highlights a comprehensive review of emerging druggable targets aimed at modulating immune checkpoint co-inhibitory as well as co-stimulatory molecules in response to immune system activation. This modulation has prompted to the development of newer therapeutic insights, eventually inducing immunogenic cell death through immunomodulatory actions. The study emphasizes the role of immune checkpoints in immunogenic regulation of cancer pathogenesis and explores potential therapeutic avenues in cancer immunotherapy. Modulation of Immunosuppressive and Immunostimulatory pathways of immune checkpoints in cancer immunotherapy
      datePublished:2024-10-01T00:00:00Z
      dateModified:2024-10-01T00:00:00Z
      pageStart:1879
      pageEnd:1913
      sameAs:https://doi.org/10.1007/s10495-024-02022-8
      keywords:
         Cancer immunotherapy
         Immune cells
         Co-inhibitory immune checkpoints
         Co-stimulatory immune checkpoints
         Immunomodulation
         Cancer Research
         Cell Biology
         Oncology
         Biochemistry
         general
         Virology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-024-02022-8/MediaObjects/10495_2024_2022_Figb_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-024-02022-8/MediaObjects/10495_2024_2022_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-024-02022-8/MediaObjects/10495_2024_2022_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-024-02022-8/MediaObjects/10495_2024_2022_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-024-02022-8/MediaObjects/10495_2024_2022_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-024-02022-8/MediaObjects/10495_2024_2022_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-024-02022-8/MediaObjects/10495_2024_2022_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-024-02022-8/MediaObjects/10495_2024_2022_Fig8_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-024-02022-8/MediaObjects/10495_2024_2022_Fig9_HTML.png
      isPartOf:
         name:Apoptosis
         issn:
            1573-675X
            1360-8185
         volumeNumber:29
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Sakuntala Gayen
            affiliation:
                  name:NSHM Knowledge Campus, Kolkata-Group of Institutions
                  address:
                     name:Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata-Group of Institutions, Kolkata, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Swarupananda Mukherjee
            affiliation:
                  name:NSHM Knowledge Campus, Kolkata-Group of Institutions
                  address:
                     name:Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata-Group of Institutions, Kolkata, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sandipan Dasgupta
            affiliation:
                  name:Maulana Abul Kalam Azad University of Technology
                  address:
                     name:Department of Pharmaceutical Technology, Maulana Abul Kalam Azad University of Technology, Kolkata, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Souvik Roy
            url:http://orcid.org/0000-0003-2980-0362
            affiliation:
                  name:NSHM Knowledge Campus, Kolkata-Group of Institutions
                  address:
                     name:Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata-Group of Institutions, Kolkata, India
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Apoptosis
      issn:
         1573-675X
         1360-8185
      volumeNumber:29
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:NSHM Knowledge Campus, Kolkata-Group of Institutions
      address:
         name:Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata-Group of Institutions, Kolkata, India
         type:PostalAddress
      name:NSHM Knowledge Campus, Kolkata-Group of Institutions
      address:
         name:Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata-Group of Institutions, Kolkata, India
         type:PostalAddress
      name:Maulana Abul Kalam Azad University of Technology
      address:
         name:Department of Pharmaceutical Technology, Maulana Abul Kalam Azad University of Technology, Kolkata, India
         type:PostalAddress
      name:NSHM Knowledge Campus, Kolkata-Group of Institutions
      address:
         name:Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata-Group of Institutions, Kolkata, India
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Sakuntala Gayen
      affiliation:
            name:NSHM Knowledge Campus, Kolkata-Group of Institutions
            address:
               name:Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata-Group of Institutions, Kolkata, India
               type:PostalAddress
            type:Organization
      name:Swarupananda Mukherjee
      affiliation:
            name:NSHM Knowledge Campus, Kolkata-Group of Institutions
            address:
               name:Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata-Group of Institutions, Kolkata, India
               type:PostalAddress
            type:Organization
      name:Sandipan Dasgupta
      affiliation:
            name:Maulana Abul Kalam Azad University of Technology
            address:
               name:Department of Pharmaceutical Technology, Maulana Abul Kalam Azad University of Technology, Kolkata, India
               type:PostalAddress
            type:Organization
      name:Souvik Roy
      url:http://orcid.org/0000-0003-2980-0362
      affiliation:
            name:NSHM Knowledge Campus, Kolkata-Group of Institutions
            address:
               name:Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata-Group of Institutions, Kolkata, India
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata-Group of Institutions, Kolkata, India
      name:Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata-Group of Institutions, Kolkata, India
      name:Department of Pharmaceutical Technology, Maulana Abul Kalam Azad University of Technology, Kolkata, India
      name:Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata-Group of Institutions, Kolkata, India
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(955)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.18s.